$NA CytRx Oncology Corp Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CytRx Oncology Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CytRx Oncology Corp. Insider overview, share value development, latest insider transactions and email notifications about new events in CytRx Oncology Corp for free.
IRS Number: 743123261
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: NA
Company Address: 555 MADISON AVENUE, 25TH FLOOR NEW YORK 10022
Former name: Innovive Pharmaceuticals, Inc., date of change: 2005-08-26
Former name: Innovive Pharmaceuticals, Inc., date of change: 2005-08-26
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
CytRx Oncology Corp Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23 2008 | NA | CytRx Oncology Cor ... | LOBELL J JAY | Director | Option Exercise | D | 4.36 | 530 | 2,311 | 0 | |
| Sep 23 2008 | NA | CytRx Oncology Cor ... | LOBELL J JAY | Director | Option Exercise | D | 3.96 | 30,000 | 118,800 | 0 | |
| Sep 23 2008 | NA | CytRx Oncology Cor ... | LOBELL J JAY | Director | Sell | D | 0.00 | 162,670 | 0 | 0 | 162.7 K to 0 (-100.00 %) |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Pfaffle Antony | Director | Option Exercise | D | 3.96 | 30,000 | 118,800 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Kelly Steven | President and CEO | Option Exercise | D | 5.00 | 112,500 | 562,500 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Kelly Steven | President and CEO | Option Exercise | D | 4.00 | 112,500 | 450,000 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Kelly Steven | President and CEO | Option Exercise | D | 3.96 | 156,301 | 618,952 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Kelly Steven | President and CEO | Sell | D | 0.00 | 158,000 | 0 | 0 | 158 K to 0 (-100.00 %) |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | DECARO ANGELO | Director | Option Exercise | D | 3.85 | 30,000 | 115,500 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | DECARO ANGELO | Director | Sell | D | 0.00 | 20,000 | 0 | 0 | 20 K to 0 (-100.00 %) |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Poma Eric E | VP - Business Devel ... | Option Exercise | D | 3.96 | 60,000 | 237,600 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Poma Eric E | VP - Business Devel ... | Option Exercise | D | 5.00 | 37,500 | 187,500 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Poma Eric E | VP - Business Devel ... | Option Exercise | D | 4.00 | 37,500 | 150,000 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Poma Eric E | VP - Business Devel ... | Option Exercise | D | 0.45 | 100,000 | 45,000 | 0 | |
| Sep 22 2008 | NA | CytRx Oncology Cor ... | Poma Eric E | VP - Business Devel ... | Sell | D | 0.00 | 63,160 | 0 | 0 | 63.2 K to 0 (-100.00 %) |